CYNO Cynosure - Class A (MM)

WESTFORD, Mass., March 11 /PRNewswire-FirstCall/ -- Cynosure, Inc. (NASDAQ:CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that President and Chief Executive Officer Michael Davin and Chief Financial Officer Tim Baker will present at the following institutional investor conferences in March: -- On Monday, March 17, the Company will present at the Cowen and Company 28th Annual Health Care Conference, taking place at The Boston Marriott Copley Place. The presentation will begin at 2:30 p.m. ET. -- On Wednesday, March 19, Cynosure will present at the Citi Investment Research 2008 Small and Mid-Cap Conference, taking place at the Four Seasons at Mandalay Bay, Las Vegas. The presentation will begin at 1:45 p.m. ET. These presentations will be available via live audio webcast and archived replay through the "Investor Relations" section of Cynosure's website, http://www.cynosure.com/. To access the webcast, click on the link titled "Events." About Cynosure, Inc. Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions, laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd: YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991. For corporate or product information, contact Cynosure at 800-886-2966, or visit http://www.cynosure.com/. Contact: Scott Solomon Vice President Sharon Merrill Associates, Inc. 617.542.5300 DATASOURCE: Cynosure, Inc. CONTACT: Scott Solomon, Vice President of Sharon Merrill Associates, Inc., for Cynosure, Inc., +1-617-542-5300, Web site: http://www.cynosure.com/

Copyright